The Shifting Landscape of Pharma Investment: Acquiring Biotech Companies Over Research

Richard A Meyer
3 min readApr 11, 2024

Resource allocation has significantly transformed in the ever-evolving pharma industry landscape in recent years. Traditionally, pharma companies invested heavily in in-house research and development (R&D) to fuel innovation and bring new drugs to market. However, a noticeable shift has occurred, with a growing trend towards acquiring biotech…

--

--

Richard A Meyer

Marketing and Political thought leader — Writer- Audiophile